ECM
ADPT icon

ExodusPoint Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

ExodusPoint Capital Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.7M Buy
+555,020
New +$8.84M 0.06% 302
2025
Q1 		– Sell
-246,865
Closed -$1.48M – 1405
2024
Q4 		$1.48M Buy
+246,865
New +$1.36M 0.01% 821
2024
Q1 		– Sell
-763,885
Closed -$3.74M – 1451
2023
Q4 		$3.74M Sell
763,885
-111,190
-13% -$507K 0.02% 403
2023
Q3 		$4.77M Buy
875,075
+734,803
+524% +$4.86M 0.05% 384
2023
Q2 		$941K Buy
140,272
+112,068
+397% +$833K 0.01% 1123
2023
Q1 		$249K Sell
28,204
-62,813
-69% -$554K ﹤0.01% 1517
2022
Q4 		$695K Sell
91,017
-254,547
-74% -$1.98M 0.01% 1072
2022
Q3 		$2.46M Buy
345,564
+308,252
+826% +$2.9M 0.03% 697
2022
Q2 		$302K Sell
37,312
-169,454
-82% -$1.49M ﹤0.01% 1535
2022
Q1 		$2.87M Buy
206,766
+193,889
+1,506% +$3.05M 0.04% 607
2021
Q4 		$361K Buy
+12,877
New +$395K ﹤0.01% 1582
2021
Q1 		– Sell
-10,843
Closed -$641K – 2074
2020
Q4 		$641K Sell
10,843
-1,271
-10% -$65.5K 0.01% 1100
2020
Q3 		$589K Sell
12,114
-72,402
-86% -$3.04M 0.01% 930
2020
Q2 		$4.09M Buy
+84,516
New +$3.08M 0.11% 200
2019
Q4 		– Sell
-11,908
Closed -$368K – 1491
2019
Q3 		$368K Sell
11,908
-70,225
-86% -$2.87M 0.01% 795
2019
Q2 		$3.97M Buy
+82,133
New +$3.64M 0.16% 87

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ExodusPoint Capital Management's ADPT Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in Adaptive Biotechnologies (ADPT) in Q1 2026: 555,020 shares worth $7.7M. The stake represents 0.06% of the portfolio and ranks #302 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in ADPT as recently as Q4 2024.

ExodusPoint Capital Management first reported a position in ADPT in Q2 2019 and has held it in 16 quarters since. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • ExodusPoint Capital Management held 555,020 shares of Adaptive Biotechnologies worth $7.7M as of Q1 2026.
  • Adaptive Biotechnologies was a new ExodusPoint Capital Management position in Q1 2026.
  • Adaptive Biotechnologies made up 0.06% of ExodusPoint Capital Management's portfolio in Q1 2026, its #302 holding.
  • ExodusPoint Capital Management first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 16 quarters since.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.